When medical therapy of BPH is not indicated or ineffective, surgical intervention is required. A variety of minimally invasive surgical techniques are also offered in the program. The Urological Cancer Program is also under the direction of Dr. Herbert Lepor. Since treatment of cancer often requires multidisciplinary efforts, NYU urologists work closely with medical oncologists and radiotherapists. Cancers of the prostate, bladder, and kidney are the most common malignancies treated in the program.
Treatment is tailored to each patient's priorities and objectives.
Among the aims of the program are preserving erectile function after radical prostate cancer surgery, creating continent neobladders in combination with cystectomy for bladder cancer, and preserving male fertility after retroperitoneal lymph node dissections for testicular cancer. Dr. Lepor was one of the key investigators involved in the development of nerve-sparing retropubic prostatectomy, a technique that preserves sexual function while curing prostate cancer by complete removal of the malignancy. Dr. Lepor has performed more than 400 such operations. His results in terms of retained continence and potency, operative complications, and length of hospitalization are among the best in the nation. M.D. Incontinence is a socially embarrassing and often debilitating problem that may reflect a number of treatable urologic disorders.